Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. 2005

Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
Molecular Virology Section, Laboratory of Molecular Microbiology, National Institutes of Allergy and Infectious Diseases, Maryland 20892-0460, USA.

Human immunodeficiency virus type 1 viral protein R (Vpr) is required for viral pathogenesis and has been implicated in T-cell apoptosis through its activation of caspase 3 and caspase 9 and perturbation of mitochondrial membrane potential. To understand better Vpr-mitochondria interaction, we report here the identification of antiapoptotic mitochondrial protein HAX-1 as a novel Vpr target. We show that Vpr and HAX-1 physically associate with each other. Overexpression of Vpr in cells dislocates HAX-1 from its normal residence in mitochondria and creates mitochondrion instability and cell death. Conversely, overexpression of HAX-1 suppressed the proapoptotic activity of Vpr.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016336 Gene Products, vpr Trans-acting proteins which accelerate retroviral virus replication. The vpr proteins act in trans to increase the levels of specified proteins. vpr is short for viral protein R, where R is undefined. vpr Gene Products,vpr Protein,Gene Product, vpr,Viral Protein R,Viral Protein R (vpr),Protein R, Viral,vpr Gene Product
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
December 1997, Journal of virology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
April 2007, Microbes and infection,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
February 1998, Journal of virology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
February 2001, Journal of virology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
March 2008, Journal of virology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
March 2007, Journal of molecular biology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
October 2004, Journal of virology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
April 2004, DNA and cell biology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
April 1998, Journal of virology,
Venkat S R K Yedavalli, and Hsiu-Ming Shih, and Yu-Ping Chiang, and Chun-Yi Lu, and Luan-Yin Chang, and Mao-Yuan Chen, and Che-Yen Chuang, and Andrew I Dayton, and Kuan-Teh Jeang, and Li-Min Huang
July 1998, Journal of virology,
Copied contents to your clipboard!